Gene: EPB41L5
Official Full Name: erythrocyte membrane protein band 4.1 like 5provided by HGNC
Gene Summary: Predicted to enable cytoskeletal protein binding activity and protein domain specific binding activity. Predicted to be involved in actomyosin structure organization. Predicted to act upstream of or within several processes, including chordate embryonic development; embryonic foregut morphogenesis; and mesoderm morphogenesis. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17954 | EPB41L5 Knockout cell line (HeLa) | Human | EPB41L5 | 1:3~1:6 | Negative | Online Inquiry |
KO17955 | EPB41L5 Knockout cell line (HCT 116) | Human | EPB41L5 | 1:2~1:4 | Negative | Online Inquiry |
KO17956 | EPB41L5 Knockout cell line (HEK293) | Human | EPB41L5 | 1:3~1:6 | Negative | Online Inquiry |
KO17957 | EPB41L5 Knockout cell line (A549) | Human | EPB41L5 | 1:3~1:4 | Negative | Online Inquiry |
EPB41L5 Gene Knockout Cell Lines represent a cutting-edge biotechnological tool designed to facilitate the study of the EPB41L5 gene, known for its role in various cellular mechanisms, including cytoskeletal organization and cellular adhesion. These cell lines are engineered through advanced gene editing techniques, such as CRISPR-Cas9, to disrupt the EPB41L5 gene, allowing researchers to investigate the functional consequences of gene loss and the underlying molecular pathways involved.
The primary function of the EPB41L5 Gene Knockout Cell Lines is to serve as a controlled model system for studying the specific effects of EPB41L5 deficiency on cellular behaviors, including proliferation, migration, and response to external stimuli. By utilizing these knockout lines, researchers can elucidate the gene's roles in various physiological and pathological contexts, helping to identify potential therapeutic targets for diseases related to cytoskeletal dysfunction, such as cancer and muscular dystrophies.
The scientific importance of these cell lines lies in their application across diverse research areas, particularly in cell biology, genetics, and drug development. They provide invaluable insights that can drive innovation in therapeutic strategies and enhance our understanding of gene function in health and disease. Unlike traditional models, these knockout cell lines offer a precise and reproducible means to quantify the impact of the EPB41L5 gene in vitro, making them an attractive option for both basic and translational research.
One of the unique selling points of our EPB41L5 Gene Knockout Cell Lines is their high specificity and reliability compared to alternatives such as traditional siRNA approaches or general knockout strategies that may affect multiple genes inadvertently. This specificity ensures that results are directly attributable to the EPB41L5 gene, enhancing the validity of experimental outcomes.
For researchers and clinicians focused on understanding and manipulating genetic pathways, EPB41L5 Gene Knockout Cell Lines provide a robust platform that can accelerate discovery and inform clinical applications. With our commitment to quality and innovation, backed by a team of experienced scientists, our products are designed to empower the scientific community and advance biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.